Showing 1601-1610 of 1841 results for "".
- Orasis Pharmaceuticals Presents New Data Showing Qlosi Is Pupil Selective in Presbyopic Eyeshttps://modernod.com/news/orasis-pharmaceuticals-presents-new-data-showing-qlosi-is-pupil-selective-in-presbyopic-eyes/2485470/Orasis Pharmaceuticals announced new clinical data demonstrating that Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4% is pupil selective, significantly reducing pupil diameter without a statistically significant change in ciliary muscle response in presb
- ViaLase Announces Strategic Leadership Transitionshttps://modernod.com/news/vialase-announces-strategic-leadership-transitions/2482876/ViaLase announced changes to its executive leadership team as the company prepares for commercial launch and regulatory approvals in both the United States and Europe. Tibor Juhasz, PhD, founder and former Chief Executive Officer, has transitioned to
- Study Identifies How Diabetes Slows Healing in the Eyehttps://modernod.com/news/study-identifies-how-diabetes-slows-healing-in-the-eye/2481742/Investigators from Cedars-Sinai have provided new understanding of how diabetes delays wound healing in the eye, identifying for the first time two related disease-associated changes to the cornea, according to a company news release.
- Euclid Systems Names Key Leadership Hires and Announces Major Facility Expansionhttps://modernod.com/news/euclid-systems-names-key-leadership-hires-and-announces-major-facility-expansion/2480465/Euclid Systems announced two additions to its leadership team as well as the expansion of its manufacturing facility in Sterling, Virginia. The changes come at a time when Euclid’s next-gene
- Prediabetes Linked to Macular Thinninghttps://modernod.com/news/prediabetes-linked-to-macular-thinning/2478592/Prediabetes is associated with significant thinning of the macula and with decreases in retinal-artery diameters, according to a population-based study. Various retinal changes have been reported in individuals with impaired fasting glucose or hyperglycemia, but it remains unclear whether
- WSJ: Troubled COVID-19 Data System Returning to CDChttps://modernod.com/news/wsj-troubled-covid-19-data-system-returning-to-cdc/2478184/The U.S. Department of Health and Human Services is reversing course on a change to the way hospitals report critical information on the coronavirus pandemic to the government, returning the responsibility for data collection to the Centers for Disease Control and Prevention, according to a W
- AstraZeneca Takes COVID-19 Vaccine to China With BioKangtai Deal for 200M-Dose Capacity by 2021https://modernod.com/news/astrazeneca-takes-covid-19-vaccine-to-china-with-biokangtai-deal-for-200m-dose-capacity-by-2021/2478134/Last week China was a notable missing element in AstraZeneca’s COVID-19 vaccine strategy, despite being the drugmaker’s second-largest market. That has changed, according to a FiercePharma
- Diabetic Retinopathy Approaches Refined by New Trial Resultshttps://modernod.com/news/diabetic-retinopathy-approaches-refined-by-new-trial-results/2477686/Data from clinical trials are prompting leading diabetic retinopathy specialists to change their approach to treatment, according to a Medscape report. The Protocol studies conducted by the DRCR Retina Network, which is funded by t
- CMS Provides Regulatory Relief on Staffing, Paperwork as COVID-19 Cases Surgehttps://modernod.com/news/cms-provides-regulatory-relief-on-staffing-paperwork-as-covid-19-cases-surge/2477504/The Trump administration released a raft of regulatory changes intended to bolster hospitals including setting up alternative sites of care and methods to rapidly boost healthcare workers, according to a FierceHealthcare
- Johnson & Johnson Appoints Kelly Heaps, Vice President of US Sales, Vision Carehttps://modernod.com/news/johnson-johnson-appoints-kelly-heaps-vice-president-of-us-sales-vision-care/2482879/Johnson & Johnson announced the appointment of Kelly Heaps as Vice President of US Sales, Vision Care. As the leader of the US Sales Organization, Ms. Heaps will work to accelerate sales and foster market share growth while collaborating with customers to strengthen patient outcomes.